Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering 10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide.

Client Email

Product

10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide #
HEALTH CANADA PATENTS

PharmaCompass Sponsored Ads

Contact Supplier

Bora Pharmaceuticals- Making success more certain.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Axplora- The partner of choice for complex APIs.

Contact Supplier

Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Contact Supplier

10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide #

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

62 API Suppliers, 28 USDMF, 11 CEP/COS, 14 EU WC, 6 KDMF, 27 NDC API, 36 Listed Suppliers, $ API Reference Price

62 API Suppliers
28 USDMF
11 CEP/COS
14 EU WC
6 KDMF
27 NDC API
36 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Imports

INTERMEDIATES

3 API Suppliers

3 API Suppliers

FINISHED DOSAGE FORMULATIONS

178 FDF Dossiers, 64 FDA Orange Book, 81 Europe, 6 Canada, 7 Australia, 4 South Africa, 16 Listed Dossiers

178 FDF Dossiers
64 FDA Orange Book
81 Europe
6 Canada
7 Australia
4 South Africa
16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 150MG, TABLET;ORAL - 300MG, TABLET;ORAL - 600MG

TABLET;ORAL - 150MG
TABLET;ORAL - 300MG
TABLET;ORAL - 600MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 4 Rochem International Inc, 7 SPI Pharma, 2 Seqens, 8 DKSH, 3 Jai Radhe Sales, 1 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 13 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 4 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 36 BASF, 1 Clariant, 13 Corel Pharma Chem, 3 DFE Pharma, 2 Finar, 14 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 11 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 18 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 5 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 25 Roquette, 16 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

72 Coating Systems & Additives, 65 Fillers, Diluents & Binders, 41 Solubilizers, 41 Controlled & Modified Release, 40 Direct Compression, 37 Disintegrants & Superdisintegrants, 36 Thickeners and Stabilizers, 25 Granulation, 25 Film Formers & Plasticizers, 22 Topical, 22 Lubricants & Glidants, 19 Taste Masking, 19 Parenteral, 17 Co-Processed Excipients, 13 Chewable & Orodispersible Aids, 11 Emulsifying Agents, 10 Rheology Modifiers, 8 API Stability Enhancers, 7 Surfactant & Foaming Agents, 5 Coloring Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 1 Soft Gelatin

72 Coating Systems & Additives
65 Fillers, Diluents & Binders
41 Solubilizers
41 Controlled & Modified Release
40 Direct Compression
37 Disintegrants & Superdisintegrants
36 Thickeners and Stabilizers
25 Granulation
25 Film Formers & Plasticizers
22 Topical
22 Lubricants & Glidants
19 Taste Masking
19 Parenteral
17 Co-Processed Excipients
13 Chewable & Orodispersible Aids
11 Emulsifying Agents
10 Rheology Modifiers
8 API Stability Enhancers
7 Surfactant & Foaming Agents
5 Coloring Agents
5 Empty Capsules
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

24 NEWS #PharmaBuzz

24 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 54 Finished Drug Prices, 1 Annual Reports

3 US Medicaid Prescriptions
54 Finished Drug Prices
1 Annual Reports

MARKET PLACE

13 APIs, 1 FDF Dossiers

13 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

33 US Patents, 6 Health Canada Patents

33 US Patents
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 6 USP, 9 Others

2 EDQM
6 USP
9 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 161 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 4Gowling Strathy & Henderson

02 2Blank

filter Patent Reset all filters

6 All

01 62277791

filter Product Reset all filters

6 All

01 4Oxcarbazepine

02 2Blank

filter Dosage Reset all filters

6 All

01 1Oral Suspension

02 3Tablets

03 2Blank

filter Exp Date Reset all filters

6 All

01 42008-02-12

02 22018-02-12

Nuray Oxcarbazepine

US Patents
Health Canada Patents

Product Main Page

01

Gowling Strathy & Henderson

Oxcarbazepine

Discovery on Target

Not Confirmed

Gowling Strathy & Henderson

Canada

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-02-12

Date Granted : 2008-11-18

Oxcarbazepine

Brand Name : TRILEPTAL

Patent Number : 2277791

Filing Date : 1998-02-12

Strength per Unit : 150mg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-02-12

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling Strathy & Henderson

Oxcarbazepine

Discovery on Target

Not Confirmed

Gowling Strathy & Henderson

Canada

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2008-02-12

Date Granted : 2008-11-18

Oxcarbazepine

Brand Name : TRILEPTAL

Patent Number : 2277791

Filing Date : 1998-02-12

Strength per Unit : 600mg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2008-02-12

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling Strathy & Henderson

Oxcarbazepine

Discovery on Target

Not Confirmed

Gowling Strathy & Henderson

Canada

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2008-02-12

Date Granted : 2008-11-18

Oxcarbazepine

Brand Name : TRILEPTAL

Patent Number : 2277791

Filing Date : 1998-02-12

Strength per Unit : 300mg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2008-02-12

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Gowling Strathy & Henderson

Oxcarbazepine

Discovery on Target

Not Confirmed

Gowling Strathy & Henderson

Canada

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-02-12

Date Granted : 2008-11-18

Oxcarbazepine

Brand Name : TRILEPTAL

Patent Number : 2277791

Filing Date : 1998-02-12

Strength per Unit : 60mg / ml

Dosage Form : Oral Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-02-12

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Oxcarbazepine

Discovery on Target

Not Confirmed

Country

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2008-02-12

Date Granted :

Oxcarbazepine

Brand Name :

Patent Number : 2277791

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2008-02-12

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Oxcarbazepine

Discovery on Target

Not Confirmed

Country

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2008-02-12

Date Granted :

Oxcarbazepine

Brand Name :

Patent Number : 2277791

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2008-02-12

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?